28 years of biopharma R&D experience (including nearly 20 years at MSD)

Fellow of the American Statistical Association (ASA) and Scholar of Center for Innovative Study Design at Stanford University

Co-chair for the ASA real-world scientific working group (2022 – 2024)

Editorial board for the Journal of Biopharmaceutical Statistics and Contemporary Clinical Trials

Graduated from Medical College of Peking University.

With more than 16-year work experience in Clinical Development/Medical Affairs and 11-year people management experience in MNC pharma, global CRO, and biotech companies. 

Has worked on more than 30 phase I-III trials including 10+ global MRCT trials covering from non-tumor to tumor indication (CNS/Pain, Solid tumors, Immune diseases, Anti-infectious/COVID-19, AAV gene therapy, rare disease).

MS in Physiology, Peking University.

Over ten years of industry experience. Worked in IQVIA, Novartis and other global pharmaceutical companies, CROs and start-up biotech companies, with rich experience in project management and clinical operations. Successfully conducted phase I to III clinical trials in China and multi-countries/regions, including APAC, the Middle East, North America, Eastern Europe throughout from IND to NDA.

Doctor of Biostatistics and Epidemiology, University of Tokyo.

Over 20 years of experience in statistical support for drug development and nearly 10 years of experience in managing statistical teams. Worked for Pfizer and Hengrui and successfully supported the marketing of 10+ products for 20+ indications. With extensive experience in the full life cycle of oncology and non-oncology drug development.

Bachelor of Clinical Medicine, Gannan Medical University; EMBA, China Europe International Business School.

17 years of medical and marketing related experience in the pharmaceutical industry and over 10 years of experience in team management. Worked for Roche, Yidu Tech, McCann and public hospitals. Responsible for and involved in the development and implementation of medical and marketing strategies for products in multiple disease areas before and after they come into the market. Participated in and promoted the application and development of real-world studies.

Major of Pharmacy, China Pharmaceutical University; MBA of Fudan university. 

9 years related experience in clinical trials, TOP 10 years working experience in MNC；Promoting on the basis of IRC assess clinical efficacy and safety of the project the expansion of the solution and fall to the ground, and new technologies, such as AI research platform construction and commercialization.

Bachelor of Pharmacy, Wenzhou Medical University; MBA, Zhejiang University.

15 years of experience in business and market development in the pharmaceutical industry, and more than 10 years of experience in team and client management. Worked for pharmaceutical companies such as Pfizer, Bayer and Biotech Pharma, as well as Taimei Technology, and served as the head of the business development center of B2B and Imaging Science successively.

Majored in computer and engineering structure and mechanics at Wuhan University of Technology.

Over 16 years of experience in Internet technology companies. Worked for well-known Internet companies in China. Joined Taimei Technology as VP in 2017, specializing in industrial Internet platform development and operation, digital patient resource platform development and operation, subject recruitment, DCT solutions, etc. Obtained 19 healthcare related digital R&D patents.

Bachelor's degree, Shanghai Jiao Tong University; MBA, Business School Netherlands.

Nearly 13 years of industry experience, has worked in IQVIA, FMD and pharmas, has been responsible for ClinOps team management, project oversight and KA management. Jeff has participated in multiple clinical trials of new drugs and successfully passed the NMPA inspection.

Postgraduate from Sichuan University.

More than 15 years of experience in clinical trial management in top global CROs, with projects covering phases I-IV, and therapeutic areas involving tumors (ovarian cancer, breast cancer, NSCLC, pancreatic cancer, lymphoma, etc.), diabetes, blood diseases, infectious diseases, renal diseases, autoimmune diseases, etc., including 8 new drugs which got approved for marketing and successfully passed NMPA verification.

Master of Medicine, Liaoning University of TCM; MBA, Remin University of China.

Over 15 years’ experience in clinical trial industry,  worked in the top global companies such as IQVIA, Covance, ICON, Medtronic, has rich therapeutic experience such as solid tumor, hematological malignancy, endocrine disease, cardiovascular disease, gastrointestinal disease, immune disease, dermatological disease, rare disease and medical device. Several products from his previous trials have been approved. He also led several NMPA inspections successfully.

Bachelor of Science in Radiology, Soochow University 15 years of experience in clinical trials including 10 years in project management, encompassing the overall lifecycle management of new drugs from Phase I to Phase IV. Expertise spans various therapeutic areas including oncology (liver, breast, ovarian, lung), autoimmune diseases, ophthalmology, gastroenterology, respirology, cardiovascular, and metabolism, etc. 8 years of experience in top MNCs (Roche and AstraZeneca), 5 years of experience in leading biotechnology companies (Zai Lab and Harbour BioMed), and 2 years of experience in a global CRO (Parexel). Involved in the clinical work for multiple new drug applications and successfully navigated them through NMPA inspections for approval and launch.

Academy Military Medical Science, Master of Clinical Oncology.

Wenxiao has over 15 years’ working experience in pharmaceutical industry，held relevant medical positions and team management in multinational and local pharmaceutical companies, including CRO, MNC (Pfizer, Roche) , Biotech (CStone and I-MAB) , etc, involved in the clinical develop process of multiple solid tumor therapeutic area and new oncology compounds.

15 years of industry medical affair , worked at AstraZeneca, Eli Lilly, Takeda, CTTQ , experienced at RWE and medical affairs team management , built a medical team from 0 to 1 around RWS.Published more than 30 RWE in the past, and lead more than 60 post-marketing clinical research projects.

Master of Public Health, University of Sheffield, UK.

Over 11 years of experience in clinical trial data management in top CROs worldwide. Worked in IQVIA, Covance for data management and team management, covering various therapeutic areas such as phase I-IV oncology, endocrine, cardiovascular diseases, respiratory diseases, infection, immunity, etc.

PMP certified

Master of Biometrics, Nanjing Medical University.

Has 15 years of experience in clinical data analysis and rich experience in project management. Successively served at multinational pharmaceutical companies and large CRO companies. Has project experience in cardiovascular diseases, endocrinology, ophthalmology, central nervous system, oncology, etc. Participated in data submission to different regulatory authorities for over 50 projects. Has rich experience in the design of data standard, automation and process of clinical trials.

Master of Clinical Medicine, Soochow University and visiting scholar at Creighton University.

With many years of experience in clinical practice and research in hospitals. Responsible for several oncology projects as PI. Specialized in oncology, neurology, anti-infection and other therapeutic areas. Also responsible for pharmacovigilance and team management in CROs and pharmaceutical companies for a long time, involving medical review, signaling and risk assessment, strategies for safety evaluation, establishment of pharmacovigilance systems and standardization of quality management.

Master of Pharmaceutical Chemistry, Hebei University.

More than 6 years of experience in pharmacovigilance, working as operation experts in pharmacovigilance-related services, service operation team management, etc.. Provided services of pharmacovigilance solutions for 100+ pharmaceutical companies. Provided pharmacovigilance services and project management for 100+ domestic and international pharmaceutical companies throughout the life cycle, including clinical phase I-IV, post-marketing research, and post-marketing full services.

Master of Pharmaceutical Analysis, China State Institute of Pharmaceutical Industry

About 10 years of experience in the pharmaceutical R&D industry, 6+ years of PV experience. Worked as PV solution expert, overseas PV service operation, and overseas business team management, accumulated a complete experience from solution consulting to implementation and management; Provided PV solution consulting services to nearly 200 domestic companies and MNC; Managed 100+ projects for 50+ clients, covering regulatory agencies, local and global pharmaceutical companies and CROs, involving the whole life cycle PV work